Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tina Rönn

Tina Rönn

Assistant researcher

Tina Rönn

Genome-Wide DNA and Histone Modification Studies in Metabolic Disease

Author

  • Charlotte Ling
  • Tina Rönn

Summary, in English

The last decade has witnessed a revolution in genetic technology, where genome-wide analyses, covering the majority of genetic variation, were thought to explain disease-causing mechanisms in common metabolic disorders. However, these genetic data only explain a modest proportion of the estimated heritability of type 2 diabetes and obesity and hence suggest a potential role for epigenetic variation in the etiology of metabolic disease. Indeed, recent genome-wide epigenetic studies have identified altered DNA methylation patterns in human pancreatic islets, adipose tissue, skeletal muscle, and blood from subjects with type 2 diabetes compared with normal subjects. Also, measures of obesity, such as increased body mass index (BMI), have been associated with epigenetic modifications in humans. It should also be noted that environmental risk factors for metabolic disease, for example, energy-rich diets, physical inactivity, and aging have been found to alter the epigenetic pattern genome-wide and in candidate genes for type 2 diabetes and obesity in human tissues. Additionally, interactions between genetic and epigenetic variations seem to contribute to the risk for metabolic disease. Together, genome-wide epigenetic studies highlight the importance of altered DNA methylation and histone modifications in the pathogenesis of metabolic disease. This chapter aims at summarizing current knowledge in the field of metabolic disease and genome-wide epigenetic analyses in humans.

Department/s

  • Diabetes - Epigenetics
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2015-10-28

Language

English

Pages

255-270

Publication/Series

Epigenomics in Health and Disease

Document type

Book chapter

Publisher

Elsevier Inc.

Topic

  • Medical Genetics
  • Endocrinology and Diabetes

Keywords

  • Adipose tissue
  • DNA methylation
  • Epigenetics
  • Genome-wide
  • Histone modifications
  • Human
  • Metabolic disease
  • Obesity
  • Pancreatic islets
  • Skeletal muscle
  • Type 2 diabetes

Status

Published

Research group

  • Diabetes - Epigenetics

ISBN/ISSN/Other

  • ISBN: 9780128001400
  • ISBN: 9780128004968